Report of the independent panel considering the retraction of two articles in The BMJ (original) (raw)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
Alessandro Montedori
The Lancet, 2005
View PDFchevron_right
More clarity needed on the true benefits and risks of statins
Aseem Malhotra
Prescriber, 2016
View PDFchevron_right
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy
Jordan Fulcher
American Heart Journal, 2016
View PDFchevron_right
How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease
Uffe Ravnskov
Expert review of clinical pharmacology, 2015
View PDFchevron_right
Formal comment on “Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease”
Malcolm Kendrick
PLOS ONE
View PDFchevron_right
Of statins and low-density lipoprotein cholesterol, "fats" and fiction
Ambrish Mithal
Indian journal of endocrinology and metabolism
View PDFchevron_right
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
Isabella Ghement
QJM, 2011
View PDFchevron_right
Cholesterol reduction yields clinical benefit: impact of statin trials
Lawrence Gould
Circulation, 1998
View PDFchevron_right
Meta-analysis of Placebo-Controlled Randomized Controlled Trials on the Prevalence of Statin Intolerance
Richard A Krasuski
The American journal of cardiology, 2017
View PDFchevron_right
Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis
David Prieto-Merino
BMC Medicine, 2014
View PDFchevron_right
Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins
Mohammad Tavakkoli
American Journal of Epidemiology, 2012
View PDFchevron_right
Role of Statins in the Primary Prevention of Atherosclerotic Cardiovascular Disease and Mortality in the Population with Mean Cholesterol in the Near-Optimal to Borderline High Range: A Systematic Review and Meta-Analysis
Sanjay Srivatsa
2020
View PDFchevron_right
Statin therapy: more than meets the eye?
Jack McCain
Managed care (Langhorne, Pa.), 2004
View PDFchevron_right
The large clinical statin trials
Stefan Agewall
International Journal of Cardiology, 2011
View PDFchevron_right
On Statins, Strokes, Meta-Analyses, Competing Risks, and the Onward March of Science
Robert Belloto
Annals of Pharmacotherapy, 2007
View PDFchevron_right
Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists’ Collaboration meta-analysis for low-density lipoprotein lowering
Curt Furberg
Journal of Clinical Lipidology, 2012
View PDFchevron_right
A Point-by-Point Response to Recent Arguments Against the Use of Statins in Primary Prevention
Sameer Chaudhari
Clinical Cardiology, 2012
View PDFchevron_right
Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials
Andrés Contreras
Cardiovascular Therapeutics, 2020
View PDFchevron_right
Meta-Analysis of Cardiovascular Outcomes Trials Comparing Intensive Versus Moderate Statin Therapy
Benjamin Steinberg
Journal of the American College of Cardiology, 2006
View PDFchevron_right
Interpretation of the evidence for the effi cacy and safety of statin therapy
Lucia Cordeiro
View PDFchevron_right
Clinical Outcomes in Statin Treatment Trials
Don Luo
Archives of Internal Medicine, 1999
View PDFchevron_right
Should Statin Therapy Be Allocated on the Basis of Global Risk or on the Basis of Randomized Trial Evidence?
Steven Jones
The American Journal of Cardiology, 2010
View PDFchevron_right
Statins in patients with peripheral artery disease: A protocol for a systematic review and network meta-analysis
Thiago Fidale
Internal Medicine and Care, 2018
View PDFchevron_right
Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease
Maarten Leening
JAMA Cardiology, 2016
View PDFchevron_right
Prevalence of statin intolerance: a meta-analysis
Peter E Penson
European heart journal, 2022
View PDFchevron_right
Impact of statin dose on major cardiovascular events: A mixed treatment comparison meta-analysis involving more than 175,000 patients
Patricia Ziegelmann
International Journal of Cardiology, 2013
View PDFchevron_right